- Report
- October 2023
- 420 Pages
Global
From €2799EUR$2,900USD£2,401GBP
- Report
- March 2024
- 199 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 180 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 196 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 195 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- September 2023
- 249 Pages
Global
From €4766EUR$5,111USD£3,950GBP
- Report
- September 2023
- 98 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- February 2024
- 250 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 250 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 250 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- December 2023
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- November 2023
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- November 2023
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- March 2024
- 185 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2024
- 915 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- November 2023
- 138 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- November 2023
- 148 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- February 2024
- 75 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- April 2024
- 183 Pages
Global
From €4729EUR$4,900USD£4,057GBP
Car T therapies are a type of immunotherapy used to treat certain types of cancer. They involve the use of genetically modified T cells, which are a type of white blood cell, to recognize and attack cancer cells. The T cells are taken from the patient's blood, modified in a laboratory, and then infused back into the patient's body. This type of therapy has been used to treat certain types of leukemia and lymphoma, and is being studied for use in other types of cancer.
Car T therapies are a relatively new type of oncology drug, and the market is still in its early stages. However, the potential of this type of therapy has led to a surge of interest from pharmaceutical companies, investors, and researchers. Companies are investing in research and development to improve the safety and efficacy of these therapies, as well as to expand their use to other types of cancer.
Some of the companies in the Car T therapies market include Novartis, Kite Pharma, Gilead Sciences, Juno Therapeutics, and Celgene. Show Less Read more